Salt Lake City, UT—GOED has launched a clinical study database to “illuminate the science” on EPA and DHA omega-3s, according to the press release.

The database, years in the making, was developed by GOED as a specialized search tool focused on scientific literature surrounding omega-3s. More than 50 independent research assistants helped review more than 40,000 studies on omega-3s and create the tool, which details all 4,000 human clinical trials. It offers both a high-level overview of all the literature abstracts, and a deeper curated search on omega-3 science related to different outcomes. It can be filtered by population, intervention, dosage, study characteristics, and more.

“With this tool, we’re helping researchers and scientists save countless hours of PubMed searches and journal article reading,” said Kaitlin Roke, Ph.D., Director of Scientific Communication and Outreach for GOED, in the press release. “We see companies using this to understand the body of evidence supporting their omega-3 products, help substantiate claims on marketing materials and inform product development or new research into emerging scientific areas.”

Related: GOED Publishes 2021 Edition of Annual Global Omega-3 Market Report Omega-3s for the Heart, and So Much More GOED Report Offers Insights on U.S. Supplement Users

The database is available through annual or quarterly subscription. The option is also available to commission an individual concierge project for a specific need. Members of GOED receive discounted pricing. A virtual demonstrationcan be viewed here.For more information or to schedule a personal demo, the association asks that you contact Dr. Roke